For the Inventor, By the Inventor

Enter inventor name

Cham, Switzerland

Ralf Hosse

USPTO Granted Patents = 45 (Patent Applications = 41)

CIPO Patents = 7 (Patent Applications = 17)

EPO Patents = 25 (Patent Applications = 43)

Average Co-Inventor Count = 7.8

ph-index = 13

Forward Citations = 563(Granted Patents)

Location History:

Schlieren, CH (2020 - 2023)
Mettmenstetten, CH (2020 - 2023)
Cham, CH (2014 - 2024)

Company Filing History:

Roche Glycart Ag

14 out of 4,945

Hoffmann-la Roche Inc.

Roche Glyeart Ag

6. 1 out of 3,684

Bristol-myers Squibb Compnay

Years Active: 2014-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-FAP Antibodies

Interleukin-2 Fusion Proteins

Immunoconjugates

T Cell Activating Molecules

Tumor-Targeted Antibodies

CD3 Binding Antibodies

NKG2D Antibodies

HER2 Antibodies

DR5 Specific Antibodies

Mutant Interleukin-2 Polypeptides

Anti-CEA Antibodies

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286486 - Anti-FAP antibodies and methods of use (2025-04-29),

2. 12240911 - Bispecific antibodies specific for OX40 (2025-03-04),

3. 12215155 - Antibodies binding to CD3 and CD19 (2025-02-04),

4. 12139553 - T cell activating bispecific antigen binding molecules (2024-11-12),

5. 12103982 - T cell activating bispecific antigen binding molecules (2024-10-01),

6. 11952421 - Bispecific antibodies against CD3EPSILON and ROR1 (2024-04-09),

7. 11827711 - Antibodies binding to NKG2D (2023-11-28),

8. 11787873 - Bispecific HER2 antibodies and methods of use (2023-10-17),

9. 11780920 - Antibodies binding to CD3 and CD19 (2023-10-10),

10. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1 (2023-06-13),

11. 11608376 - Tumor-targeted agonistic CD28 antigen binding molecules (2023-03-21),

12. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII (2023-02-28),

13. 11365232 - Interleukin-2 fusion proteins and uses thereof (2022-06-21),

14. 11332545 - Anti-FAP antibodies and methods of use (2022-05-17),

15. 11214622 - Antibodies specific for DR5 and methods of use (2022-01-04),

Title: Inventor Ralf Hosse - Pioneering Innovations in Cham, CH

Introduction: Ralf Hosse is a visionary inventor based in Cham, Switzerland, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ralf Hosse holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more efficient and eco-friendly future.

Career Highlights: With a career spanning over two decades, Ralf Hosse has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Ralf Hosse has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Ralf Hosse's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology in Cham, Switzerland, and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…